Related by context. All words. (Click for frequent words.) 69 mild cognitive impairment 68 nondemented 67 amnestic MCI 67 cognitively intact 67 nondiabetic 66 white matter hyperintensities 66 MMSE scores 64 APOE e4 63 normotensive 63 telomere lengths 63 BRCA1 mutations 63 microbleeds 63 cognitive impairment 63 subclinical hypothyroidism 63 Framingham Offspring Study 63 APOE allele 63 LQTS 63 brain shrinkage 62 subclinical hyperthyroidism 62 nondepressed 62 narcolepsy cataplexy 62 amnestic mild cognitive impairment 62 neurological abnormalities 62 prostate cancer CaP 61 APOE4 61 telomere length 61 APOE ε4 61 premenopausal 61 advanced adenoma 61 GBA mutations 60 elevated triglyceride levels 60 CC genotype 60 thyrotropin levels 60 sporadic ALS 60 brain lesions 60 colorectal neoplasia 60 probands 60 coronary calcification 60 coronary artery calcium 60 fasting insulin 60 MetS 60 subclinical atherosclerosis 60 carotid IMT 60 brain atrophy 60 penetrance 60 T1DM 60 NAFLD 59 cardiorespiratory fitness 59 ApoE4 gene 59 Baltimore Longitudinal Study 59 mild cognitive impairments 59 urate levels 59 metabolic abnormalities 59 HNSCC 59 nonobese 59 basal cell nevus syndrome 59 neuropathologic 59 BRCA2 mutations 59 CARDIA 59 APOE e4 gene 59 Alzheimer pathology 59 systolic dysfunction 59 MGUS 59 arterial thickening 59 Framingham Offspring 59 fasting glucose levels 59 highest tertile 59 T2DM 59 colorectal adenomas 59 autonomic dysfunction 58 microalbuminuria 58 cognitive function 58 metabolically healthy 58 perimenopausal women 58 EGFR mutations 58 hsCRP levels 58 advanced adenomas 58 FDG PET scans 58 androgen deficiency 58 familial ALS 58 allele frequencies 58 asymptomatic carotid stenosis 58 prehypertensive 58 gene APOE 58 aMCI 58 ApoE4 58 hippocampal volumes 58 serum vitamin D 58 APOE genotype 58 plasma folate 58 adenoma 58 atypical hyperplasia 58 impaired fasting glucose 58 amyloid deposits 58 APOE4 carriers 58 albumin excretion 58 subclinical 57 mild cognitive 57 proband 57 GSTM1 57 HCV infected 57 pCR 57 Multivariate analyzes 57 sCJD 57 rs# [001] 57 carotid plaque 57 neurocognitive function 57 rs# [003] 57 frontotemporal dementia 57 serum lipid levels 57 missense mutations 57 HIV uninfected 57 VaD 57 cerebral microbleeds 57 neuropathological 57 KIBRA 57 advanced neoplasia 57 hyperintense lesions 57 aged ≥ 57 familial pancreatic cancer 57 FTLD 57 Wisconsin Sleep Cohort 57 underwent CABG 57 HIV HCV coinfected 57 adenomatous polyps 57 underwent radical prostatectomy 57 hydroxyvitamin D levels 57 Lewy bodies 57 hippocampal volume 57 Mild Cognitive Impairment 57 β amyloid 57 MMSE score 56 hamartomas 56 cognitive decline 56 histologically 56 rCBF 56 normal karyotype 56 Alzheimer disease pathology 56 serum selenium 56 NHANES III 56 C#Y 56 rs# [002] 56 troponin T 56 ApoE gene 56 infarcts 56 noncarriers 56 Mild cognitive impairment 56 carotid artery thickness 56 methylation patterns 56 Subgroup analyzes 56 renal cell carcinomas 56 underwent bariatric surgery 56 K ras mutations 56 morphologic 56 CARDIA study 56 Subgroup analysis 56 amyloid deposition 56 APOE gene 56 nonpsychotic 56 nonfasting triglyceride levels 56 squamous cell lung cancer 56 asymptomatic PAD 56 aminotransferase levels 56 dietary questionnaires 56 APOE4 gene 56 gene variant 56 occipital regions 56 poor metabolizers 56 diastolic function 56 apolipoprotein E APOE 56 fasting glucose 56 MLH1 56 subcortical 56 undergone radical prostatectomy 56 nondiabetic patients 56 familial aggregation 56 lipid lowering medications 56 BMD measurements 56 neurofibrillary tangles 56 cognitive functioning 56 underwent resection 56 adiponectin concentrations 56 affective psychoses 56 undergoing radical prostatectomy 55 slow metabolizers 55 dietary glycemic index 55 serum testosterone 55 lowest tertile 55 heterozygotes 55 genetic variants associated 55 ejection fractions 55 ADPKD 55 osteosarcomas 55 cystatin C 55 shorter telomere length 55 low ptau levels 55 elevated homocysteine 55 adenomas 55 albuminuria 55 BRCA mutation 55 malignant polyps 55 heterozygous 55 Young Adults CARDIA 55 Kaplan Meier analysis 55 ABCB1 55 autopsied brains 55 knee OA 55 HbA1c levels 55 diabetes mellitus DM 55 tanned indoors 55 serum PSA 55 SORL1 gene 55 Longitudinal studies 55 #q#.# deletion syndrome 55 CHD CVD 55 HNPCC 55 glucose tolerance 55 elevated CRP 55 troponins 55 Baseline characteristics 55 PsA 55 depressive symptoms 55 germline mutations 55 Digital Mammographic Imaging 55 KRAS mutations 55 supratentorial 55 pancreatic adenocarcinoma 55 CDKN2A 55 S#A# [002] 55 serum folate 55 atherosclerotic lesions 55 2D 4D ratio 55 IgA deficiency 55 BDNF gene 55 activity MAOA 55 euthyroid 55 hsCRP 55 ventricular enlargement 55 TOMM# 55 colorectal polyp 55 nonischemic 55 APOE 55 hypogonadal 55 proliferative retinopathy 55 retrospective cohort 55 monoclonal gammopathy 55 cTnT 55 Insulin sensitivity 55 lactate dehydrogenase LDH 55 TT genotype 55 amyloid pathology 55 Prostate Lung Colorectal 55 ARVD 55 SORL1 55 femoral neck BMD 55 cardiovascular mortality 55 CFH gene 55 testosterone supplementation 55 lymphocyte counts 55 affective psychosis 55 gene expression profiles 55 IL#B 55 euthymic patients 55 familial clustering 55 autosomal dominant inheritance 55 coronary artery calcification 55 APOC3 55 metabolic syndrome MetS 55 synaptic function 55 carotid stenosis 55 PCa 55 neuroimaging studies 55 MSH2 55 impaired cognition 55 Visual acuity 55 proliferative diabetic retinopathy 55 PTPN# 54 μmol L 54 hepatocellular carcinomas 54 MYH9 gene 54 Haptoglobin 54 euthymic 54 neuropsychological tests 54 hypermethylated 54 lipid levels 54 hepatic steatosis 54 asymptomatic 54 GSTM1 gene 54 parkinsonism 54 rs# [004] 54 ADAS Cog 54 habitual snoring 54 hippocampal function 54 histologically confirmed 54 left ventricular systolic 54 LV dysfunction 54 elevated serum creatinine 54 HIV seronegative 54 TP# mutation 54 Wwox 54 #.#ng/ml 54 ε4 54 cerebrospinal fluid CSF 54 hematopoietic cancers 54 AML MDS 54 promoter methylation 54 clinically insignificant 54 aortic atherosclerosis 54 PSADT 54 immunocompetent 54 spirometric 54 fMRI scans 54 somatic mutations 54 FASPS 54 shorter telomeres 54 nondrinkers 54 osteopenic 54 genetic polymorphisms 54 hippocampal atrophy 54 neurofibrillary 54 undergoing coronary angiography 54 nmol L 54 miRNA expression 54 Osteoporotic Fractures 54 microsatellite instability 54 isolated systolic hypertension 54 homocysteine levels 54 progranulin mutations 54 variant alleles 54 ZNF# 54 de novo AML 54 serum uric acid 54 nonmelanoma skin cancers 54 metabolic syndrome 54 elevated triglycerides 54 UGT#A# * 54 NP CRNs 54 estimated glomerular filtration 54 multivariable analysis 54 fractional anisotropy 54 mIU L 54 BRCA mutations 54 THIS STUDY 54 Depressive symptoms 54 elevated LDH 54 telomere shortening 54 thyroglobulin 54 inhibin B 54 autistic traits 54 MC1R 54 GH deficiency 54 transaminase levels 54 MYCN amplification 54 spontaneous mutations 54 serum cholesterol 54 specific antigen PSA 54 chromosomal anomalies 54 microalbumin test 54 CYP#A# gene 54 gene APOE4 54 Alzheimer disease AD 54 systolic hypertension 54 biochemical markers 54 highest quintile 54 impaired glucose tolerance 54 Erectile function 54 genes predisposing 54 genetic variants 54 Swedish Mammography Cohort 54 gene expression patterns 54 depressive symptomatology 54 ICDs implanted 54 fronto temporal dementia 54 hydroxyvitamin D concentrations 54 BMI z 54 unmeasured factors 54 pathological hallmark 54 seminomas 54 microcephalin 54 T2D 54 GSTT1 54 FLT3 mutations 54 NNRTI resistance 54 biochemical recurrence 53 FXTAS 53 infantile onset 53 cardioembolic stroke 53 HGPIN 53 Communities ARIC study 53 acute myelogenous leukemia AML 53 iron deficient 53 prostate carcinogenesis 53 cortical thickness 53 medically inoperable 53 bulimia nervosa 53 CSF biomarkers 53 thyroid hormone levels 53 cognitive domains 53 bowel polyps 53 vertebral fracture 53 tau protein tangles 53 BRCA2 carriers 53 fMRIs 53 GBM tumors 53 benign breast 53 Netherlands Cohort Study 53 limiting generalizability 53 psychosocial functioning 53 alanine aminotransferase ALT 53 medial temporal 53 definite stent thrombosis 53 CVD mortality 53 AREDS 53 TEAEs 53 colorectal adenoma 53 BRCA2 mutation carriers 53 prefrontal regions 53 serum folate concentrations 53 metabolomic profiles 53 autoantibody positive 53 CLA supplementation 53 Peutz Jeghers syndrome 53 Hp2 2 53 neovascular 53 CHD mortality 53 #OHD levels 53 klotho 53 KRAS oncogene 53 hippocampal dysfunction 53 LRRK2 mutations 53 SCN5A 53 homozygous 53 SNP rs# [002] 53 left ventricular hypertrophy 53 nonfasting triglycerides 53 SLITRK1 53 apoE4 53 relapsed ALL 53 nondiabetics 53 premorbid 53 p# mutations 53 prospective longitudinal 53 Health Initiative Observational 53 elevated hsCRP 53 intermittent exotropia 53 variant allele 53 GPC5 53 vascular dysfunction 53 mitochondrial mutations 53 familial hypercholesterolemia 53 macroalbuminuria 53 clinicopathological 53 cerebral infarction 53 #q# [001] 53 T2 lesions 53 mRNA expression 53 DRD2 53 leukaemias 53 MTHFD1L gene 53 microRNA expression 53 glucose intolerance 53 underwent liver transplantation 53 coronary calcium 53 affective disorder 53 SNCA 53 Cognitive impairment 53 Cortisol levels 53 Brain scans 53 BRAF mutation 53 beta carotene supplementation 53 Colon polyps 53 genomewide 53 diastolic dysfunction 53 haplotypes 53 SIDS infants 53 schizophreniform disorder 53 liver biopsies 53 pathogenic mutations 53 apnea hypopnea index 53 metaplasia 53 enteroviral infection 53 atherogenic dyslipidemia 53 CAG repeats 53 androgen depletion 53 HOMA IR 53 poorer prognosis 53 histopathological 53 severely cognitively impaired 53 RLS sufferers 53 chromosomal rearrangement 53 DAS# scores 53 neurocognitive impairment 53 cirrhotic 53 olfactory dysfunction 53 FDDNP 53 drusen 53 kidney function 53 logistic regression model 53 Study AREDS 53 MYH9 53 serum estradiol 53 tHcy concentrations 53 prescribed statins 53 multivariate analyzes 53 postmenopausal breast cancer 53 drank decaffeinated coffee 53 serum calcium levels 53 obstructive coronary artery 53 plasma homocysteine 53 CP CPPS 53 preintervention 53 LUTS 53 liver histology 53 airflow obstruction 53 oophorectomy 53 oxygen desaturation 53 BRAF V#E 53 serum creatinine levels 53 ADNI 53 prepubertal 53 de ath 53 mitochondrial function 53 endothelial dysfunction 53 pre menopausal 53 lacunar 53 vascular dementia 53 ischemic strokes 53 CNVs 52 B7 H3 52 telomerase activity 52 serum phosphate 52 5 HTTLPR 52 creatinine levels 52 lobular breast cancer 52 lipid lowering therapy 52 androgen receptor gene 52 serum PTH 52 bile acid metabolism 52 thyroid carcinoma 52 UCRs 52 undergoing bariatric surgery 52 premenopause 52 mutated genes 52 Vascular dementia 52 Alzheimer disease vascular dementia 52 underwent coronary angiography 52 estrogen receptor negative 52 Neuregulin 1 52 univariate analyzes 52 p tau 52 mutations 52 aortic stiffness 52 DQB1 * 52 Alzheimer Disease Neuroimaging Initiative 52 colorectal neoplasms 52 gene variants 52 COMT gene 52 lateralized 52 beta amyloid peptides 52 HSCT 52 GSTP1 52 fetuin 52 lung metastases 52 Alzheimer disease 52 transgenic mouse models 52 atherothrombosis 52 RBP4 52 rheumatoid factor 52 motor neuron degeneration 52 poststroke 52 prehypertension 52 HFE gene 52 TMEM#B 52 TACI mutations 52 prefrontal cortical 52 APOE e4 allele 52 scintigraphic 52 hemoglobin A1c levels 52 Aß 52 ependymomas 52 dysbindin 52 G#D mutation 52 cortices 52 parahippocampal gyrus 52 5 HTT gene 52 Loeys Dietz 52 clinicopathologic 52 progressive neurodegenerative disorder 52 beta amyloid plaque 52 sociodemographic characteristics 52 paroxysmal AF 52 clusterin 52 proteinuria 52 comorbidities 52 LVEF 52 apolipoprotein E 52 HBeAg positive 52 cortical thinning 52 methylated genes 52 C reactive protein 52 ORMDL3 52 ischemic lesions 52 plasma homocysteine levels 52 histologically proven 52 autosomal dominant disorder 52 serum ferritin 52 hydroxyvitamin D 52 prediabetic 52 mL/min/#.# m 2 52 postmenopausal 52 nonobstructive CAD 52 elevated LDL cholesterol 52 myocardial infarctions 52 atherosclerotic disease 52 amyloid beta plaques 52 fasting blood glucose 52 malignant lesions 52 Endothelial function 52 cognitive deficits 52 clefting 52 recurrent VTE 52 neurosensory 52 gallstone disease 52 brain infarcts 52 colorectal polyps 52 presymptomatic 52 Sjögren syndrome 52 Cochrane reviewers 52 cardiac troponin 52 liver transplant recipients 52 CTEPH 52 coronary artery disease 52 plasma lipids 52 antiretroviral naïve 52 atypia 52 hyperphosphorylated tau 52 coinfected 52 microscopic hematuria 52 hyperplastic 52 onset atrial fibrillation 52 valvular disease 52 alpha synuclein gene 52 Median survival 52 cortical regions 52 timepoints 52 stone formers 52 Lp PLA2 52 aMCI precursor 52 Clusterin 52 serum BDNF 52 arterial calcification 52 hippocampi 52 circulating endothelial cells 52 coronary stenosis 52 nonalcoholic steatohepatitis NASH 52 Wernicke Korsakoff syndrome 52 Genetic variants 52 CALHM1 52 CCR5 delta# 52 polycystic ovary syndrome PCOS 52 histologic 52 VMAT2 52 Meningiomas usually occur 52 atypical moles 52 lesional 52 glycosylated hemoglobin HbA1c 52 parous women 52 PTEN gene 52 bivariate analyzes 52 mammographic density 52 LTBI 52 choroidal neovascularization 52 ductal breast cancer 52 diagnose Alzheimer disease 52 nonalcoholic steatohepatitis 52 psychiatric comorbidity 52 autoantibodies 52 Normative Aging Study 52 amyloid plaque 52 DCCT 52 VADT 52 BRCA1 BRCA2 52 Cystatin C 52 tertile 52 abnormal lipid 52 TRAF1 C5 52 plasma adiponectin 52 Screening Trial DMIST 52 AAT deficiency 52 activated microglia 52 PBMCs 52 genotyped 52 neurologic abnormalities 52 nonvertebral fractures 52 microscopic lesions 52 nontasters 52 antihypertensive therapy 52 SHBG levels 52 overt hypothyroidism 52 LDL cholesterol concentrations 52 epigenetic markers 52 #q# deletion 52 LRRK2 mutation 52 serum testosterone levels 52 LV ejection fraction 52 e4 allele 52 extrapyramidal symptoms 52 previously uncharacterized 52 serum IGF 52 de novo mutations 52 colonic mucosa 52 CYP#C# [001] 52 non affective psychosis 52 Hashimoto thyroiditis 52 microdeletions 52 IKZF1 52 apolipoprotein E4 52 amyloid beta plaque 52 CIN3 52 knobby polyps 52 SHANK3 52 subsyndromal 52 cryptogenic stroke 52 cancerous prostates removed 52 triacylglycerol concentrations 52 mice genetically altered 52 neurodevelopmental outcomes 52 relapsed MM 52 OSAHS 52 CETP gene 52 sedentary postmenopausal 52 psychiatric comorbidities 52 premenopausal breast cancer 52 NF1 52 dosing cohort 52 Excessive daytime sleepiness 52 NSTE ACS 52 cortex thickness 52 cortisol concentrations 52 breast lesions 52 disease progression 52 leptin concentrations 52 adiponectin levels 52 leukemia AML 52 Dr. Relkin 52 temporal cortex 52 hemoglobin A1c HbA1c 52 mutated K ras 52 abstainers 51 BLLs 51 homozygotes 51 neurocognitive deficits 51 neurodevelopmental outcome 51 affective disorders 51 phenotypic characteristics 51 endometrial cancers 51 SNPs 51 intima media thickness 51 posterior cingulate 51 myocardial infarction MI 51 WDR# 51 comorbidity 51 Multivariate analysis 51 neurocognitive impairments 51 #p# [001] 51 LPA gene 51 myelin breakdown 51 serous ovarian cancer 51 Atherosclerosis Risk 51 sustained ventricular tachycardia 51 urine cytology 51 primary generalized tonic 51 choroidal neovascularization CNV 51 dysglycemia 51 familial AF 51 PSA velocity 51 mesotheliomas 51 posttransplant 51 cryptogenic 51 artery stenosis 51 postmenopausal women 51 intact parathyroid hormone 51 metabolite concentrations 51 Myelodysplastic syndromes MDS 51 glycated hemoglobin levels 51 levodopa therapy 51 neuronal dysfunction 51 postmenopause 51 aminotransferases 51 autoregulation 51 HLA genes 51 chronic periodontitis 51 Coronary artery calcification 51 GABRA2 51 abdominally obese 51 eGFR 51 neovascular form 51 PTEN mutations 51 exomes 51 imaging fMRI scans 51 serum calcium 51 neurodevelopmental impairment 51 Leitzmann 51 histone modifications 51 born preterm 51 breast carcinoma 51 serum concentrations 51 DNA methylation patterns 51 Prehypertension 51 symptomatic intracerebral hemorrhage 51 deleterious mutations 51 elevated depressive symptoms 51 elevated ALT 51 migraineurs 51 RASSF1A 51 #q# deletion syndrome 51 Neovascular AMD 51 inherited mutations 51 EEG recordings 51 QT intervals 51 Velculescu 51 BRCA1 mutation carriers 51 smoldering myeloma 51 dysbindin gene 51 thrombocytopenic 51 lung function 51 transferrin saturation 51 recurrent acute pancreatitis 51 thiopurine 51 biochemical abnormalities 51 IPAH 51 lifetime abstainers 51 colorectal cancer incidence 51 coding genes 51 syndromal 51 XLHED 51 EEGs 51 HER2 expression 51 donepezil 51 Scarmeas 51 allele 51 APOL1 51 clinically meaningful improvement 51 coronary angiograms 51 anticholinergic drugs 51 Hurthle cell 51 EDSS score 51 phenotype 51 bronchoalveolar lavage fluid 51 OGG1 51 androgen deprivation 51 hip BMD 51 ELBW infants 51 serum urate levels 51 familial adenomatous polyposis 51 dapagliflozin plus 51 postintervention 51 KIF6 gene 51 anovulatory 51 paclitaxel eluting stents 51 onset diabetes mellitus 51 unipolar depression 51 essential thrombocythemia 51 typical antipsychotics 51 folate deficiency 51 overnight polysomnography 51 untreated celiac disease 51 antiretroviral naive 51 vascular cognitive impairment 51 dopaminergic therapy 51 carcinoids 51 homozygote 51 ± SD 51 SNP rs# [001] 51 primary biliary cirrhosis 51 mdx mice 51 left ventricular diastolic 51 undergoing CABG 51 indels 51 HRCT 51 gene variation 51 LRAT 51 uric acid levels 51 silent brain infarcts 51 multiple logistic regression 51 chromosome #q# [001] 51 histopathologic examination 51 genetic loci 51 lymphocytosis 51 fragility fractures 51 atopic 51 serum cortisol 51 HLA B# 51 pathologic fractures 51 DRD4 gene 51 testicular germ cell 51 cranial irradiation 51 glioma tumors 51 TGFBR1 * 6A 51 Rectal cancer 51 PRNP 51 abnormalities 51 HYVET 51 AGHD 51 gestational diabetes mellitus 51 miRNA genes 51 collected saliva samples 51 SCK difficulty 51 prostate carcinoma 51 hemodynamically significant 51 adenotonsillectomy 51 lobular carcinoma 51 PDE#A 51 heavily pretreated 51 carotid atherosclerosis 51 remyelination 51 comorbid depression 51 PALB2 51 muscle biopsies 51 HbF 51 serum lipids 51 serum markers 51 mineral density 51 NAT2 51 QTcF 51 carotid intima media 51 osteopontin 51 comorbid anxiety 51 severe periodontitis 51 bronchoalveolar lavage BAL 51 HRQOL 51 Heterozygous 51 comorbid conditions 51 clinically detectable 51 FGFR2 gene 51 seropositivity 51 MECP2 gene 51 postmenopausal hormones 51 ragweed allergic 51 colorectal carcinoma 51 cardiac dysfunction 51 APOE epsilon 4 51 relapsed AML 51 colonic polyps 51 timepoint 51 MTHFR 51 preserved systolic 51 evaluable subjects 51 AVODART 51 GH deficient 51 extraversion 51 Epidemiological studies 51 completely resected 51 autoimmune thyroiditis 51 chromosomal regions 51 prognostic significance 51 Univariate 51 Leydig cell 51 baseline HbA1c 51 sociodemographic factors 51 onset seizures 51 substudy 51 Mini Mental 51 leptin deficient 51 adenocarcinomas 51 selenium supplementation 51 cardio respiratory fitness 51 nonmelanoma 51 NFKBIA 51 idiopathic Parkinson disease 51 tHcy 51 neuroblastoma tumors 51 Bonferroni correction 51 neuropsychiatric symptoms 51 metabolic dysfunction 51 elevated fasting glucose 51 pathophysiological mechanisms 51 inflammatory markers 51 PLX STROKE targeting 51 Body Composition Study 51 LDL cholesterol levels 51 beta blocker therapy 51 cerebrovascular disease 51 premalignant 51 karyotype 51 K ras mutation 51 allostatic load 51 progressors 51 elevated serum ALT 51 phosphorylated tau 51 longitudinal studies 51 exfoliation glaucoma 51 TP# mutations 51 receiving antiretroviral therapy 51 polyp recurrence 51 elevated troponin 51 dietary intakes 51 tertiles 51 papillary renal cell carcinoma